Ondansetron: Reasons to be restrictive

被引：12

作者：

Frigerio, C

Burchwalder, PA

Spertini, F

机构：

[1] CHU VAUDOIS,DIV CLIN IMMUNOL,CH-1011 LAUSANNE,SWITZERLAND

[2] CHU VAUDOIS,DIV IMMUNOL & ALLERGY,CH-1011 LAUSANNE,SWITZERLAND

来源：

LANCET | 1996年 / 347卷 / 9013期

关键词：

D O I：

10.1016/S0140-6736(96)91720-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1484 / 1485

页数：2

共 5 条

[1] ONDANSETRON AND CHEST PAIN [J].

BALLARD, HS ;

BOTTINO, G ;

BOTTINO, J .

LANCET, 1992, 340 (8827) :1107-1107

[2] ANAPHYLACTOID-ANAPHYLACTIC REACTIONS ASSOCIATED WITH ONDANSETRON [J].

CHEN, M ;

TANNER, A ;

GALLOTORRES, H .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :862-862

[3] VALIDITY OF SKIN-TESTS TO CYCLOPHOSPHAMIDE AND METABOLITES [J].

CROMAR, BW ;

COLVIN, M ;

CASALE, TB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (06) :965-967

[4] GR-38032F (GR-C507/75) - A NOVEL COMPOUND EFFECTIVE IN THE PREVENTION OF ACUTE CISPLATIN-INDUCED EMESIS [J].

HESKETH, PJ ;

MURPHY, WK ;

LESTER, EP ;

GANDARA, DR ;

KHOJASTEH, A ;

TAPAZOGLOU, E ;

SARTIANO, GP ;

WHITE, DR ;

WERNER, K ;

CHUBB, JM .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (06) :700-705

[5] Hypersensitivity reactions associated with 5-hydroxytryptamine(3)-receptor antagonists: A class effect? [J].

Kataja, V ;

deBruijn, KM .

LANCET, 1996, 347 (9001) :584-585

← 1 →